Dive into a unique experience with this 8D emdr binaural beats session, designed to help you release stress and reset your emotions. Feel the deep relaxation as the music surrounds you, guiding your ...

Let the dynamic audio effects and binaural beats guide you into a state of heightened awareness and deep relaxation, facilitating vivid and memorable dreams. #8D #Lucid #Dreams ...

Johnson & Johnson’s JNJ fourth-quarter 2025 earnings came in at $2.46 per share, which beat the Zacks Consensus Estimate of $2.43. Earnings rose 20.6% from the year-ago period. Adjusted earnings ...

Roasted coffee may do more than wake you up—it could help control blood sugar. Researchers discovered several new coffee compounds that inhibit α-glucosidase, a key enzyme linked to type 2 diabetes.

Bariatric surgery patients and GLP-1 medication users had fat-mass reductions of 49.7% and 18%, respectively, after 2 years. Surgery led to higher fat-free mass to fat-mass ratios, suggesting more ...

Getting to sleep often takes longer than a beat. With 1 in 3 adults struggling to snooze, it’s no wonder many will try anything to get the recommended seven to nine hours or fall asleep fast. Binaural ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Also in this week's The Beat ...

KATY, Texas — A couple was attacked by their own son inside their Katy home over the weekend, Precinct 5 Constable Terry Allbritton said. Investigators say the adult male beat and strangled his ...

New weight-loss drugs are working wonders, but they’re also out of many patients’ financial reach. Enrollees in Medicare, Medicaid and most employer insurance plans generally don’t cover them.

AstraZeneca Plc’s profit rose more than analysts anticipated last quarter, buoyed by demand for its blockbuster cancer and diabetes drugs. Earnings per share, excluding some items, climbed 14% to ...

Vertex Pharmaceuticals Inc. reported third-quarter sales that beat analysts’ expectations as the biotech company’s mainstay cystic fibrosis treatment saw revenue growth, even as new drugs’ ...